![Coleen Glessner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Coleen Glessner
Compliance Officer at
EMERGENT BIOSOLUTIONS INC.
Net worth: 2 M $ as of 2026-05-30
Profile
Coleen Glessner is currently Executive VP-Quality, Ethics & Compliance at Emergent BioSolutions, Inc. since 2020.
Formerly, Ms. Glessner was Chief Quality Officer & Senior Vice President at Alexion Pharmaceuticals, Inc. from 2017 to 2021 and also served as VP, Head-R&D Quality at Alexion Pharmaceuticals,.
Inc. Education includes an undergraduate degree from the University of Pittsburgh and an MBA from the Massachusetts Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-07 | 202,201 ( 0.39% ) | 2 M $ | 2026-05-30 |
Coleen Glessner active positions
| Companies | Position | Start |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | Compliance Officer | 2020-02-29 |
Former positions of Coleen Glessner
| Companies | Position | End |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2021-07-31 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2021-07-31 |
Training of Coleen Glessner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
53
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
University of Pittsburgh
 University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Coleen Glessner
